Acusensus Ltd (ACE)

Sydney

Currency in AUD

1.24

-0.02(-1.59%)

Closed·01/09

Fair Value

Unlock Value

Day's Range

1.23

1.31

52 wk Range

0.90

2.13

Acusensus (ACE) Income Statement & Profits

Assess the Acusensus income statement (earnings report) to see how the company performs across operating and non-operating activities, including revenue, expenses and net income. Review ACE diluted EPS and profitability over the last four annual or quarterly periods.

Investors who need greater depth or who want to customise how data is presented to fit their own investment styles are able to do so via their very own InvestingPro account.

Period Ending:

2018

30/06

2019

30/06

2020

30/06

2021

30/06

2022

30/06

2023

30/06

2024

30/06

2025

30/06

2026

30/06

Total Revenues

aa.aa

42.01

49.63

59.35

86.17

Total Revenues Growth

aa.aa

+46.61%

+18.14%

+19.6%

+45.18%

Cost Of Revenues

aa.aa

23.57

27.05

32.78

50.01

Gross Profit

aa.aa

18.44

22.58

26.57

36.16

Gross Profit Growth

aa.aa

+47.73%

+22.45%

+17.66%

+36.09%

Gross Profit Margin %

aa.aa

43.9%

45.5%

44.76%

41.96%

Other Operating Expenses, Total

aa.aa

17.36

24.57

29.71

41.28

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+54.68%	+41.58%	+20.91%	+38.92%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	12.74	17.46	22.3	28.93
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.07	0.81	0.18	0.68

Operating Income

aa.aa

1.08

-1.99

-3.15

-5.12

Operating Income Growth

aa.aa

-14.11%

-284.12%

-57.77%

-62.78%

EBIT Margin %

aa.aa

2.58%

-4.02%

-5.3%

-5.94%

Net Interest Expenses

aa.aa

0.18

0.83

0.87

0.12

Net Interest Expenses Growth

aa.aa

+608.45%

+363.13%

+4.58%

-85.81%

Interest Expense, Total

aa.aa

-0.08

-0.09

-0.14

-0.5

Interest And Investment Income

aa.aa

0.26

0.92

1.01

0.63

Other Non Operating Expenses, Total

aa.aa

-0.68

0.17

0.02

EBT, Excl. Unusual Items

aa.aa

0.58

-1

-2.26

-5

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

-0

-1.07

-19.11

EBT, Incl. Unusual Items

aa.aa

0.58

-1

-3.33

-24.11

EBT, Incl. Unusual Items Growth

aa.aa

-50.5%

-274.43%

-231.7%

-624.65%

EBT, Incl. Unusual Items Margin

aa.aa

1.37%

-2.02%

-5.61%

-27.98%

Income Tax Expense

aa.aa

0.52

-0.7

0.18

Net Income to Company

aa.aa

0.06

-1.52

-2.62

-24.29

Minority Interest

aa.aa

Net Income

aa.aa

0.06

-1.52

-2.62

-24.29

Net Income Growth

aa.aa

-96.14%

-2,869.09%

-72.29%

-825.72%

Net Income Margin %

aa.aa

0.13%

-3.07%

-4.42%

-28.19%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

0.06

-1.52

-2.62

-24.29

Basic EPS - Continuing Operations

aa.aa

-0.01

-0.02

-0.16

Basic EPS - Continuing Operations Growth

aa.aa

-96.57%

-2,565.85%

-62.7%

-699.6%

Diluted EPS - Continuing Operations

aa.aa

-0.01

-0.02

-0.16

Diluted EPS - Continuing Operations Growth

aa.aa

-96.73%

-2,732.75%

-65.86%

-700%

Basic Weighted Average Shares Outstanding

aa.aa

112.29

126.3

133.75

154.85

Diluted Weighted Average Shares Outstanding

aa.aa

120.01

126.3

133.75

154.85

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

3.86

1.8

0.39

1.2

EBITDA Growth

aa.aa

+25.52%

-53.4%

-78.31%

+206.92%

EBITDA Margin %

aa.aa

9.18%

3.62%

0.66%

1.39%

EBIT

aa.aa

1.08

-1.99

-3.15

-5.12

* In Millions of AUD (except for per share items)

FAQ

What was the quarter-over-quarter change in EBITDA for Acusensus?

ACE's EBITDA changed by 2,547.06% compared to the last quarter.

How did Acusensus’s revenue change compared to the previous quarter?

Revenue changed by 13.92% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Acusensus?

In the latest quarter, Acusensus's gross profit changed by 20.53%.

FTSE 100

10,789.28

-34.98

-0.32%

DAX

25,970.11

-288.00

-1.10%

Euro Stoxx 50

6,368.35

-51.81

-0.81%

S&P 500

7,631.54

-54.60

-0.71%

Nikkei 225

66,215.34

-96.59

-0.15%

Dow Jones

52,766.88

-419.02

-0.79%

FTSE 100 Futures

10,773.40

+2.0

+0.02%

Market Movers

Name	Last	Chg. %	Vol.
BP	541.30	+5.21%	92.51M
Shell	3,432.5	+2.63%	12.61M
Glencore	597.10	+0.25%	71.18M
HSBC	1,533.40	+0.33%	26.57M
AstraZeneca	11,962.0	-0.07%	2.89M
Rolls-Royce Holdings	1,459.20	-4.64%	21.70M
Anglo American	4,113.0	-3.65%	7.07M

Name	Last	Chg. %	Vol.
Wirecard	0.6851	+5,090.15%	232.00
Barco	22.890	+189.93%	244.00
Citycon	7.42	+155.59%	2.75K
Aryzta	83.40	+101.69%	42.80K
SIG Group	24.60	+79.84%	272.53K
Stellantis NV	8.19	+75.68%	15.28M
Campari	10.12	+73.88%	762.59K

Name	Last	Chg. %	Vol.
National Bank of Greece	2.777	-83.56%	71.81K
Trane Technologies	88.17	-80.16%	1.39K
Windar Photonics Plc	6.00	-77.36%	4.28M
Future Fintech	0.60	-74.53%	788.09K
OTP Bank	12,590.0	-72.17%	0.00
CEZ as	498.40	-63.88%	576.00
Gedeon Richter	5,040.0	-61.61%	0.00

Trending Stocks

Name	Last	Chg. %	Vol.
Rolls-Royce Holdings	1,459.20	-4.64%	21.70M
BP	541.30	+5.21%	92.51M
Glencore	597.10	+0.25%	71.18M
AstraZeneca	11,962.0	-0.07%	2.89M
Tullow Oil	21.45	+4.63%	28.93M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaaaaa	1,871.50	+72.02%	3,219.35
Aaaaa Aaa	541.30	+35.95%	735.90
Aaaaaaa	2,551.00	+34.38%	3,428.03
Aaaa Aa	1,671.5	+30.83%	2,186.8
Aaaaaaaaaaaaaa	312.60	+25.24%	391.50
Aaaaaaaaaaaaaaa	731.80	+24.11%	908.24
Aaaaaaaaaaa A	8,836.0	+21.53%	10,738.4

Name	Last	Upside	Fair Value
Aaaaaaaaaa Aaaaaaaaa	1,871.50	+72.02%	3,219.35
Aaaaa Aaa	541.30	+35.95%	735.90
Aaaaaaa	2,551.00	+34.38%	3,428.03
Aaaa Aa	1,671.5	+30.83%	2,186.8
Aaaaaaaaaaaaaa	312.60	+25.24%	391.50
Aaaaaaaaaaaaaaa	731.80	+24.11%	908.24
Aaaaaaaaaaa A	8,836.0	+21.53%	10,738.4

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Acusensus Ltd (ACE)

Acusensus (ACE) Income Statement & Profits

FAQ

What was the quarter-over-quarter change in EBITDA for Acusensus?

How did Acusensus’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Acusensus?

Trending Stocks